# US 2021/0260022 A1 · Synergy for increasing energy expenditure and insulin sensitivity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0260022 A1
- Document ID: US20210260022A1
- Status: Published application
- Kind: A1
- Application number: 17/245,538
- Filed: 2021-04-30
- Published: 2021-08-26
- Earliest claimed: 2018-11-01
- Applicants: The Board of Supervisors of Louisiana State University and Agricultural and Mechanical College
- Inventors: Frank Greenway; Ann Coulter; Candida Rebello
- Web page: https://patentgrep.com/patent/US20210260022A1

## CPC

- A61K 31/352: condensed with carbocyclic rings, e.g. methantheline {(cannabinoids A61K31/658)}
- A23L 19/03: {consisting of whole pieces or fragments without mashing the original pieces}
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 31/01: Hydrocarbons
- A61K 31/015: carbocyclic
- A61K 31/047: having two or more hydroxy groups, e.g. sorbitol
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/04: Anorexiants; Antiobesity agents
- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/0053: {Mouth and digestive tract, i.e. intraoral and peroral administration}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention is directed to compositions and methods for treating metabolic disorders.

## Claims

### Claim 1

A composition comprising a therapeutically effective amount of at least one flavonoid and a therapeutically effective amount of at least one carotenoid.

### Claim 2 (depends on 1)

The composition of claim 1, further comprising a sufficient amount of a pharmaceutically acceptable carrier.

### Claim 3 (depends on 1)

The method of claim 1, wherein the composition comprises about 150 mg to about 900 mg of at least one flavonoid.

### Claim 4 (depends on 1)

The method of claim 1, wherein the composition comprises about 1 mg to about 12 mg of at least one carotenoid.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the flavonoid is naringenin.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the at least one carotenoid is selected from the group consisting of beta carotene, lycopene, or lutein.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the at least one carotenoid is beta carotene.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the composition further comprises one or more additional active agents.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the additional active agent comprises an anti-obesity agent.

### Claim 10 (depends on 2)

The composition of claim 2, wherein the composition is provided as an injectable solution, an oral dose, a topical cream, a topical gel, or a medical food.

### Claim 11

A method for treating a subject afflicted with a metabolic disorder, the method comprising administering to the subject a therapeutically effective amount of a composition comprising at least one flavonoid and at least one carotenoid.

### Claim 12 (depends on 11)

The method of claim 11, wherein the composition comprises about 150 mg to about 900 mg of at least one flavonoid.

### Claim 13 (depends on 11)

The method of claim 11, wherein the composition comprises about 1 mg to about 12 mg of at least one carotenoid.

### Claim 14 (depends on 11)

The method of claim 11, wherein the flavonoid is naringenin.

### Claim 15 (depends on 11)

The method of claim 11, wherein the at least one carotenoid is selected from the group consisting of beta carotene, lycopene, or lutein.

### Claim 16 (depends on 11)

The method of claim 11, wherein the at least one carotenoid is beta carotene.

### Claim 17 (depends on 11)

The method of claim 11, wherein the metabolic disorder comprises obesity, insulin resistance, type 2 diabetes, metabolic syndrome, and non-alcoholic steohepatis.

### Claim 18 (depends on 11)

The method of claim 11, wherein the composition is administered as a topical cream, administered as a topic gel, administered as a medical food, or administered as an injectable.

### Claim 19 (depends on 18)

The method of claim 18, wherein the topical cream is administered locally.

### Claim 20

A method of converting white fat to brown fat in a subject, the method comprising administering to the subject a therapeutically effective amount of a composition comprising at least one flavonoid and at least one carotenoid.

### Claim 21 (depends on 20)

The method of claim 20, wherein the composition comprises about 150 mg to about 900 mg of at least one flavonoid.

### Claim 22 (depends on 20)

The method of claim 20, wherein the composition comprises about 1 mg to about 12 mg of at least one carotenoid.

### Claim 23 (depends on 20)

The method of claim 20, wherein the flavonoid is naringenin.

### Claim 24 (depends on 20)

The method of claim 20, wherein the at least one carotenoid is selected from the group consisting of beta carotene, lycopene, or lutein.

### Claim 25 (depends on 20)

The method of claim 20, wherein the at least one carotenoid is beta carotene.

### Claim 26 (depends on 20)

The method of claim 20, wherein the composition is administered as a topical cream, administered as a topic gel, administered as a medical food, administered as an oral dose, or administered as an injectable.

### Claim 27 (depends on 26)

The method of claim 26, wherein the topical cream is administered locally.

### Claim 28

A method for local fat reduction, the method comprising administering to a site on a subject a therapeutically effective amount of a composition comprising at least one flavonoid and at least one carotenoid.

### Claim 29 (depends on 28)

The method of claim 28, wherein the composition comprises about 150 mg to about 900 mg of at least one flavonoid.

### Claim 30 (depends on 28)

The method of claim 28, wherein the composition comprises about 1 mg to about 12 mg of at least one carotenoid.

### Claim 31 (depends on 28)

The method of claim 28, wherein the flavonoid is naringenin.

### Claim 32 (depends on 28)

The method of claim 28, wherein the at least one carotenoid is selected from the group consisting of beta carotene, lycopene, or lutein.

### Claim 33 (depends on 28)

The method of claim 28, wherein the at least one carotenoid is beta carotene.

### Claim 34 (depends on 21)

The method of claim 21, wherein the composition is administered as a topical cream, administered as a topic gel, or administered as an injectable.
